These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37592321)

  • 1. Efferocytosis of viable versus heat-inactivated MSC induces human monocytes to distinct immunosuppressive phenotypes.
    Schrodt MV; Behan-Bush RM; Liszewski JN; Humpal-Pash ME; Boland LK; Scroggins SM; Santillan DA; Ankrum JA
    Stem Cell Res Ther; 2023 Aug; 14(1):206. PubMed ID: 37592321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire.
    Davies LC; Queckbörner S; Jylhä CE; Andrén AT; Forshell TZP; Blanc KL
    Cytotherapy; 2023 Sep; 25(9):956-966. PubMed ID: 37354149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling.
    Quarato ER; Salama NA; Li AJ; Smith CO; Zhang J; Kawano Y; McArthur M; Liesveld JL; Becker MW; Elliott MR; Eliseev RA; Calvi LM
    Cell Death Dis; 2023 Jul; 14(7):428. PubMed ID: 37452070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells.
    de Witte SFH; Luk F; Sierra Parraga JM; Gargesha M; Merino A; Korevaar SS; Shankar AS; O'Flynn L; Elliman SJ; Roy D; Betjes MGH; Newsome PN; Baan CC; Hoogduijn MJ
    Stem Cells; 2018 Apr; 36(4):602-615. PubMed ID: 29341339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of heat-inactivated, secretome-deficient MSC and metabolically active MSC in sepsis and allogenic heart transplantation.
    Weiss ARR; Lee O; Eggenhofer E; Geissler E; Korevaar SS; Soeder Y; Schlitt HJ; Geissler EK; Hoogduijn MJ; Dahlke MH
    Stem Cells; 2020 Jun; 38(6):797-807. PubMed ID: 32101344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
    Zimmermann JA; Hettiaratchi MH; McDevitt TC
    Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MSCs promote the efferocytosis of large peritoneal macrophages to eliminate ferroptotic monocytes/macrophages in the injured endometria.
    Wang J; Li J; Yin L; Wang X; Dong Y; Zhao G; Shen S; Hou Y
    Stem Cell Res Ther; 2024 May; 15(1):127. PubMed ID: 38693589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory function of licensed human bone marrow mesenchymal stromal cell-derived apoptotic bodies.
    Wang J; Donohoe E; Canning A; Moosavizadeh S; Buckley F; Brennan MÁ; Ryan AE; Ritter T
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111096. PubMed ID: 37871378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
    Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
    J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs.
    Weiss ARR; Dahlke MH
    Front Immunol; 2019; 10():1191. PubMed ID: 31214172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.
    Chinnadurai R; Copland IB; Garcia MA; Petersen CT; Lewis CN; Waller EK; Kirk AD; Galipeau J
    Stem Cells; 2016 Sep; 34(9):2429-42. PubMed ID: 27299362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-
    Lee HJ; Kim HD; Jo CH; Bok EY; Kim SB; Lee SL; Jang M; Bae SG; Yun SH; Kim SJ; Rho GJ; Lee WJ
    Biomed Res Int; 2021; 2021():4604856. PubMed ID: 34527737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical cord-mesenchymal stem cells induce a memory phenotype in CD4
    Sengun E; Wolfs TGAM; van Bruggen VLE; van Cranenbroek B; Simonetti ER; Ophelders D; de Jonge MI; Joosten I; van der Molen RG
    Front Immunol; 2023; 14():1128359. PubMed ID: 37409122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells.
    Chinnadurai R; Copland IB; Patel SR; Galipeau J
    J Immunol; 2014 Feb; 192(4):1491-501. PubMed ID: 24403533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.